Why the study?
Singapore's rapidly ageing population and lifestyle transitions have contributed to a rising cancer burden, requiring robust projections of future incidence and costs to inform capacity planning, financing, and policy.
Population
268,189 incident cancer cases diagnosed from 2000-2021 in the Singapore Cancer Registry
Design
Population-based projection and cost-modeling study
Follow-up
Minimum follow-up of five years
Key result
Annual cancer incidence in Singapore is projected to increase 3.3-fold to 7.59 per 1,000 population by 2050, with five-year national medical expenditures expected to reach US 23.6 billion.
Authors
Loading...
Clinicians must scale early detection and prevention efforts; extends prior models and leaves open sustainable financing solutions.
Singapore faces a dramatic escalation in cancer incidence and healthcare costs by 2050, underscoring the urgent need for early detection and sustainable financing models.
Wee et al. (2026) studied this question. Annual cancer incidence in Singapore is projected to increase 3.3-fold to 7.59 per 1,000 population by 2050, with five-year national medical expenditures expected to reach US 23.6 billion.